Strive Health
Strive Health provides value-based kidney care using its CareMultiplier™ platform and Kidney Heroes® teams to support patients with kidney disease.
Secondary Market Price
Secondary Market Price
How Strive Health Measures Up
To help you manage your Strive Health equity, Prospect has run the company through our machine learning model.
Prospect Rating
TBD
We are still gathering data and evaluating Strive Health. Check back soon for our rating on the company's potential worth four years from now.
Exit Risk
TBD
We are still gathering data on Strive Health to train our machine learning model. Check back soon for our exit risk rating for Strive Health!
Funding Stage
Series D
A Series D funding round suggests Strive Health is a mature, well-established company, which can mean more stability and job security than an earlier-stage startup. This stage also indicates a strong focus on scaling, creating opportunities for you to grow your career as the company expands.
Secondary Market Price Chart
Create a free account to unlock real-time secondary market prices and future projections of Strive Health's value.
Sign up to Unlock the Latest DataData will be available soon.
Sign up to receive notifications when it is available.
Prospect Projected Future Strive Health Prices
Prospect’s machine learning model has been trained on the same data top-tier investors use to project the likely range of outcomes for Strive Health's equity. Create a free account to view 10th-90th percentile projections over 2, 4, and 6 years.
Powerful tools to earn more from your equity
Company Description
Strive Health is a value-based kidney care provider that partners with payors and health systems to manage care for patients with chronic kidney disease (CKD) and end-stage kidney disease (ESKD). The company uses a model that combines technology-enabled interventions with local provider networks to support patients from early-stage disease through dialysis. It currently serves over 145,000 patients in 50 states through a network of more than 6,500 providers. Strive Health was founded in 2018 in Denver, Colorado, by Chris Riopelle and Will Stokes, inspired by Riopelle’s experience watching a friend navigate kidney disease. The company treated its first patient in April 2020.
Looking forward, the company is deploying artificial intelligence in nine different projects to improve patient care and reduce provider administrative tasks, including AI-driven scheduling and transcribing provider-patient conversations. Recent company data shows its patient education programs have contributed to an 85% increase in optimal dialysis starts and a 62% increase in home dialysis adoption. A peer-reviewed study also found that Strive Health's care model reduced the rate of CKD progression by up to 77.2% in people with late-stage kidney disease. The company's growth is supported by a recent capital raise of $550 million.
- NEA
- Redpoint
- CapitalG
- CVS Health
- Ascension Ventures
- Echo Health
- Co-founder, Chief Executive Officer Chris Riopelle
- Co-founder, Advisor Will Stokes
Peer Group Comparison
Vs Peer Group of >$4B Startups
Frequently Asked Questions
Joining Anduril as an employee is another way to acquire equity, typically through stock options included in compensation packages.
Is Strive Health worth joining?
Deciding whether to join a private company like Strive Health depends on your personal career goals and risk tolerance. Evaluating the compensation package, including the equity component, is a critical step in making an informed decision.
What should I do with my Strive Health stock?
Your strategy for managing private stock should align with your financial goals and tax situation. Platforms like Prospect offer tools to help you create tax-optimized exercise strategies and model different financial scenarios for your equity.
Can you sell Strive Health stock?
As Strive Health is a private company, its stock is not publicly traded and is generally illiquid. Selling shares is typically only possible during company-approved events like a tender offer or on a secondary market.
How can I find the value of my Strive Health stock?
The value of private stock is typically determined by a 409A valuation or the price set in a recent funding round. To help forecast potential future value, you can use tools like Prospect’s predictive models, which are trained on venture capital data.
What is Strive Health's equity worth?
The precise worth of Strive Health's equity is based on its private valuation, which is not public information. This valuation can change significantly based on company performance and future funding rounds.
What is Strive Health's stock ticker symbol?
Strive Health does not have a stock ticker symbol because it is a private company. Ticker symbols are only assigned to companies whose shares are listed and traded on a public stock exchange.
Can I buy or sell Strive Health stock?
Buying shares in a private company is typically restricted to accredited investors during funding rounds, while selling is limited to specific liquidity events. Tools like Prospect can help existing shareholders optimize their decisions when an opportunity to sell arises.
What is the criteria to buy or invest in Strive Health stock?
Investing in a private startup like Strive Health is generally limited to institutional investors or accredited investors who meet specific SEC-defined income or net worth thresholds. These opportunities are not typically available to the general public before an IPO.
